Literature DB >> 28329087

Clinical Definitions of Sarcopenia and Risk of Hospitalization in Community-Dwelling Older Men: The Osteoporotic Fractures in Men Study.

Peggy M Cawthon1,2, Li-Yung Lui1, Brent C Taylor3,4,5, Charles E McCulloch2, Jane A Cauley6, Jodi Lapidus7, Eric Orwoll7, Kristine E Ensrud3,4,5.   

Abstract

BACKGROUND: The association between various definitions of sarcopenia and hospitalization has not been evaluated in community-dwelling older men.
METHODS: We used data from 1,516 participants at Visit 3 of the Osteoporotic Fractures in Men (MrOS) study who also had linked Medicare Fee-For-Service Claims data available. We examined the association between several sarcopenia definitions (International Working Group, European Working Group for Sarcopenia in Older Persons, Foundation for the NIH Sarcopenia Project, Baumgartner, and Newman) and hospitalization, using two-part ("hurdle") models, adjusted for age, clinical center, functional limitations, self-reported health, comorbidity, and cognitive function. Predictors included sarcopenia status (the summary definitions and the components of slowness, weakness, and/or lean mass); outcomes included hospitalization and cumulative inpatient days/year in the 3 years following the Visit 3 exam.
RESULTS: After accounting for confounding factors, none of the summary definitions or the definition components (slowness, weakness, or low lean mass) were associated with likelihood of hospitalization, the rate ratio of inpatient days among those hospitalized, or the mean rate of inpatient days amongst all participants.
CONCLUSIONS: Sarcopenia was not associated hospitalization in community-dwelling older men. These results provide further evidence that current sarcopenia definitions are unlikely to identify those who are most likely to have greater hospitalization.
© The Author 2017. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Epidemiology; Gait; Hospital related; Sarcopenia

Mesh:

Year:  2017        PMID: 28329087      PMCID: PMC5861971          DOI: 10.1093/gerona/glw327

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  17 in total

Review 1.  Gender gap in longevity and disability in older persons.

Authors:  A B Newman; J S Brach
Journal:  Epidemiol Rev       Date:  2001       Impact factor: 6.222

2.  Mortality risk in older men associated with changes in weight, lean mass, and fat mass.

Authors:  Christine G Lee; Edward J Boyko; Carrie M Nielson; Marcia L Stefanick; Douglas C Bauer; Andrew R Hoffman; Thuy-Tien L Dam; Jodi A Lapidus; Peggy Mannen Cawthon; Kristine E Ensrud; Eric S Orwoll
Journal:  J Am Geriatr Soc       Date:  2011-02-02       Impact factor: 5.562

3.  Epidemiology of sarcopenia among the elderly in New Mexico.

Authors:  R N Baumgartner; K M Koehler; D Gallagher; L Romero; S B Heymsfield; R R Ross; P J Garry; R D Lindeman
Journal:  Am J Epidemiol       Date:  1998-04-15       Impact factor: 4.897

4.  Comorbidity measures for use with administrative data.

Authors:  A Elixhauser; C Steiner; D R Harris; R M Coffey
Journal:  Med Care       Date:  1998-01       Impact factor: 2.983

5.  Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men.

Authors:  Eric Orwoll; Janet Babich Blank; Elizabeth Barrett-Connor; Jane Cauley; Steven Cummings; Kristine Ensrud; Cora Lewis; Peggy M Cawthon; Robert Marcus; Lynn M Marshall; Joan McGowan; Kathy Phipps; Sherry Sherman; Marcia L Stefanick; Katie Stone
Journal:  Contemp Clin Trials       Date:  2005-10       Impact factor: 2.226

6.  Overview of recruitment for the osteoporotic fractures in men study (MrOS).

Authors:  Janet Babich Blank; Peggy Mannen Cawthon; Mary Lou Carrion-Petersen; Loretta Harper; J Phillip Johnson; Eileen Mitson; Romelia Ramírez Delay
Journal:  Contemp Clin Trials       Date:  2005-10       Impact factor: 2.226

7.  Anti-myostatin antibody increases muscle mass and strength and improves insulin sensitivity in old mice.

Authors:  João-Paulo G Camporez; Max C Petersen; Abulizi Abudukadier; Gabriela V Moreira; Michael J Jurczak; Glenn Friedman; Christopher M Haqq; Kitt Falk Petersen; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-08       Impact factor: 11.205

8.  The healthcare costs of sarcopenia in the United States.

Authors:  Ian Janssen; Donald S Shepard; Peter T Katzmarzyk; Ronenn Roubenoff
Journal:  J Am Geriatr Soc       Date:  2004-01       Impact factor: 5.562

9.  Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.

Authors:  Alfonso J Cruz-Jentoft; Jean Pierre Baeyens; Jürgen M Bauer; Yves Boirie; Tommy Cederholm; Francesco Landi; Finbarr C Martin; Jean-Pierre Michel; Yves Rolland; Stéphane M Schneider; Eva Topinková; Maurits Vandewoude; Mauro Zamboni
Journal:  Age Ageing       Date:  2010-04-13       Impact factor: 10.668

10.  Sarcopenia and length of hospital stay.

Authors:  A S Sousa; R S Guerra; I Fonseca; F Pichel; T F Amaral
Journal:  Eur J Clin Nutr       Date:  2015-12-16       Impact factor: 4.016

View more
  19 in total

Review 1.  Total-Body PET Imaging of Musculoskeletal Disorders.

Authors:  Abhijit J Chaudhari; William Y Raynor; Ali Gholamrezanezhad; Thomas J Werner; Chamith S Rajapakse; Abass Alavi
Journal:  PET Clin       Date:  2021-01

Review 2.  Ultrasound and magnetic resonance imaging as diagnostic tools for sarcopenia in immune-mediated rheumatic diseases (IMRDs).

Authors:  Fausto Salaffi; Marina Carotti; Andrea Di Matteo; Luca Ceccarelli; Sonia Farah; Catalina Villota-Eraso; Marco Di Carlo; Andrea Giovagnoni
Journal:  Radiol Med       Date:  2022-09-20       Impact factor: 6.313

3.  Sarcopenia and catastrophic health expenditure by socio-economic groups in China: an analysis of household-based panel data.

Authors:  Chen Ye; Xu Zheng; Sumiya Aihemaitijiang; Ruoyu Wang; Mairepaiti Halimulati; Xiaojie Huang; Zhaofeng Zhang
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-04-26       Impact factor: 12.063

Review 4.  Health Consequences of Sarcopenic Obesity: A Narrative Review.

Authors:  Eun Roh; Kyung Mook Choi
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-21       Impact factor: 5.555

5.  Sarcopenia as a predictor of hospitalization among older people: a systematic review and meta-analysis.

Authors:  Xiaoming Zhang; Wenwu Zhang; Conghua Wang; Wuyuan Tao; Qingli Dou; Yunzhi Yang
Journal:  BMC Geriatr       Date:  2018-08-22       Impact factor: 3.921

6.  Sarcopenia: revised European consensus on definition and diagnosis.

Authors:  Alfonso J Cruz-Jentoft; Gülistan Bahat; Jürgen Bauer; Yves Boirie; Olivier Bruyère; Tommy Cederholm; Cyrus Cooper; Francesco Landi; Yves Rolland; Avan Aihie Sayer; Stéphane M Schneider; Cornel C Sieber; Eva Topinkova; Maurits Vandewoude; Marjolein Visser; Mauro Zamboni
Journal:  Age Ageing       Date:  2019-01-01       Impact factor: 10.668

7.  Association of sarcopenic obesity with the risk of all-cause mortality among adults over a broad range of different settings: a updated meta-analysis.

Authors:  Xiaoming Zhang; Xiaohua Xie; Qingli Dou; Chenyun Liu; Wenwu Zhang; Yunzhi Yang; Renli Deng; Andy S K Cheng
Journal:  BMC Geriatr       Date:  2019-07-03       Impact factor: 3.921

8.  Sarcopenia, Diet, Physical Activity and Obesity in European Middle-Aged and Older Adults: The LifeAge Study.

Authors:  Pablo Jorge Marcos-Pardo; Noelia González-Gálvez; Abraham López-Vivancos; Alejandro Espeso-García; Luis Manuel Martínez-Aranda; Gemma María Gea-García; Francisco Javier Orquín-Castrillón; Ana Carbonell-Baeza; José Daniel Jiménez-García; Daniel Velázquez-Díaz; Cristina Cadenas-Sanchez; Emanuele Isidori; Chiara Fossati; Fabio Pigozzi; Lorenzo Rum; Catherine Norton; Audrey Tierney; Ilvis Äbelkalns; Agita Klempere-Sipjagina; Juris Porozovs; Heikki Hannola; Niko Niemisalo; Leo Hokka; David Jiménez-Pavón; Raquel Vaquero-Cristóbal
Journal:  Nutrients       Date:  2020-12-22       Impact factor: 5.717

9.  Sarcopenia prevalence and associations with mortality and hospitalisation by various sarcopenia definitions in 85-89 year old community-dwelling men: a report from the ULSAM study.

Authors:  Sigvard Sobestiansky; Karl Michaelsson; Tommy Cederholm
Journal:  BMC Geriatr       Date:  2019-11-20       Impact factor: 3.921

10.  Acute mechanical, physiological and perceptual responses in older men to traditional-set or different cluster-set configuration resistance training protocols.

Authors:  Antonio Dello Iacono; Domenico Martone; Lawrence Hayes
Journal:  Eur J Appl Physiol       Date:  2020-08-10       Impact factor: 3.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.